Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 AB INBEV ABI 25. avr 2025 57.32 -1.58   
 Ackermans & van Haaren NV ACKB 25. avr 2025 211.00 +0.67   
 Aedifica SA AED 25. avr 2025 67.75 +0.52   
 Ageas AGS 25. avr 2025 53.70 -0.09   
 Argen X SE ARGX 25. avr 2025 535.80 +0.79   
 Azelis Group NV AZE 25. avr 2025 13.61 +3.42   
 Bel20 BEL20 25. avr 2025 4 306.05 +0.37   
 Cofinimmo COFB 25. avr 2025 65.70 +1.62   
 D`ieteren Group DIE 25. avr 2025 169.10 +0.36   
 Elia Group SA/NV ELI 25. avr 2025 89.50 -0.72   
 Groupe Bruxelles Lambert SA GBLB 25. avr 2025 71.50 +0.70   
 KBC Groupe NV KBC 25. avr 2025 82.22 +1.28   
 Lotus Bakeries NV LOTB 25. avr 2025 8 190.00 -1.68   
 Melexis NV MELE 25. avr 2025 54.35 0.00   
 Sofina SA SOF 25. avr 2025 243.20 +0.41   
 Solvay SA SOLB 25. avr 2025 32.92 +1.04   
 Syensqo S.A. SYENS 25. avr 2025 60.28 -0.30   
 UCB SA UCB 25. avr 2025 149.70 +1.59   
 Umicore SA UMI 25. avr 2025 8.36 +2.14   
 Warehouses De Pauw SA WDP 25. avr 2025 21.96 -0.45   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.